Managing Burnout in the Pharmacy
Pharmacy Times
SEPTEMBER 25, 2023
Physical symptoms of burnout can include headaches, digestive problems, sleep disturbances, and increased susceptibility to illnesses due to a weakened immune system.
September, 2023
167 
CVS Pharmacists, Staff in Kansas City Stage Walkout Over Working Conditions
Drug Topics
SEPTEMBER 26, 2023
Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacies and Labs Must Work Together to Accelerate Test and Treat Opportunities, Enhance Patient Care Equity, Improve Health Outcomes
Pharmacy Times
SEPTEMBER 27, 2023
Working together, pharmacies and labs can answer the call to align and back legislation that supports pharmacists as providers, help patients gain greater access to affordable care, and reap the benefits of improved health outcomes while growing business revenue.
The 2023 PharmaVoice 100
PharmaVoice
SEPTEMBER 19, 2023
This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
WHO recommends dropping component of many flu vaccines
STAT
SEPTEMBER 29, 2023
The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.
FTC sues PE-backed anesthesia provider for monopolistic roll-ups, price setting
Fierce Healthcare
SEPTEMBER 21, 2023
Federal regulators have accused a major Texas-based anesthesia provider and its parent private equity firm of a decade-long, three-pronged scheme to suppress competition and drive-up prices. | U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe, its private equity backer, have "cost Texans tens of millions of dollars more each year" by suppressing competition over the course of a decade, the regulator alleges.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Pharmacists Work to Sustain Care in Health Care Deserts
Drug Topics
SEPTEMBER 29, 2023
When rural areas lose hospitals and primary care clinics, residents must turn to pharmacies to receive the care they need.
HHS Recommends Cannabis Move From Schedule 1 to Schedule 3, the Result Will Impact Opportunities for Drug Research
Pharmacy Times
SEPTEMBER 19, 2023
Moving cannabis to Schedule 3 will make it easier to research, resulting in the development and creation of new cannabinoid-based pharmaceuticals, with notable potential in oncology.
Three years after an FDA rejection, DBV sees a path for its peanut patch
PharmaVoice
SEPTEMBER 22, 2023
Despite lower-than-expected demand for a competing treatment, DBV’s chief medical officer says the company’s topical skin patch could be a game-changing option for patients.
Exodus of life scientists from academia reaches historic levels, new data show
STAT
SEPTEMBER 28, 2023
New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Oracle Health integrates generative AI, voice tech into EHR system to automate medical note-taking
Fierce Healthcare
SEPTEMBER 19, 2023
Software giant Oracle has integrated generative AI services into its Cerner electronic medical record system as health IT companies race to harness this cutting-edge tech for providers. | Software giant Oracle has integrated generative AI services into its Cerner EHR system as health tech companies race to harness this cutting-edge tech for providers.
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
SEPTEMBER 7, 2023
Demand is so strong for Novo Nordisk’s obesity drugs that the only limitation on sales—in the short term—seems to be the company’s ability to produce them. | Promising heart data for Novo Nordisk's Wegovy are a "paradigm shift," according to J.P. Morgan, which has doubled its market projection for GLP-1 diabetes and obesity treatments to $71 billion for 2032.
Breaking: Class Action Lawsuit Filed Against CVS Health, Caremark, Aetna to Recoup DIR Fees
Drug Topics
SEPTEMBER 27, 2023
The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.
Increased Vitamin D Intake Can Decrease Symptoms of Depression, Anxiety
Pharmacy Times
SEPTEMBER 8, 2023
Although findings indicate a relationship between vitamin D and mood disorders, further research is needed to clarify efficacy of specific vitamin D levels, as well as supplement dose and form.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Endangered horseshoe crabs could lead the charge in pharma’s animal-free future
PharmaVoice
SEPTEMBER 18, 2023
An effort to spare the species from blood collection is one of many ways the industry is turning away from animals for R&D.
STAT+: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story
STAT
SEPTEMBER 27, 2023
On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.
How Amazon's $4B investment in AI company Anthropic impacts healthcare
Fierce Healthcare
SEPTEMBER 27, 2023
Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. | Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. The collaboration introduces more competition and more options for healthcare teams looking to innovate using different approaches or to get more tactical with their AI strategy, one health IT expert said.
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
SEPTEMBER 22, 2023
Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. | Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. Following a series of trial shortfalls this year in melanoma, colorectal cancer and head and neck squamous cell carcinoma, the duo has missed the mark in yet another set of clinical trials—this time in non-small cell lung cancer.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Technology Tools Increase Patient Safety in the Pharmacy
Drug Topics
SEPTEMBER 18, 2023
From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.
Study Shows Not All IVIG Products Are Created Equal in Alzheimer Disease
Pharmacy Times
SEPTEMBER 12, 2023
One IVIG product showed overall improvement in neuroprotection, including alleviating cognitive decline and ameliorating AB deposition in Alzheimer disease.
Elderly exclusion: Clinical trials still fall short enrolling older adults
PharmaVoice
SEPTEMBER 25, 2023
Despite high rates of disease in older populations, systemic issues are keeping them out of research studies.
Rollout of Covid vaccines is bumpy, but not unexpected, experts say
STAT
SEPTEMBER 26, 2023
The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous
Geisinger doubles down on collaboration with Best Buy Health, Geek Squad to support tech-driven care in the home
Fierce Healthcare
SEPTEMBER 12, 2023
As at-home healthcare becomes more tech-driven—think wireless biosensors and connected blood pressure cuffs—it creates more logistical challenges for providers. | Geisinger's pilot program with Best Buy's Geek Squad resulted in quicker access to care, better adherence to care plans and more positive outcomes for chronic care patients, the organizations said.
Novartis targets first-line use for radiotherapy Lutathera with trial win in neuroendocrine tumors
Fierce Pharma
SEPTEMBER 25, 2023
More than five years after an initial FDA approval, Novartis is touting positive trial results for its radiotherapy Lutathera as a first-line therapy against the rare cancer that killed Apple co-fo | More than five years after an initial FDA approval, Novartis is touting positive trial results for its radiotherapy Lutathera as a first-line therapy against the rare cancer that killed Apple co-founder Steve Jobs.
Pharmacy Organizations Establish Pharmacy Workforce Suicide Awareness Day
Drug Topics
SEPTEMBER 20, 2023
Suicides among health care professionals are estimated to occur at a higher rate than in the general public.
Independent Rx Forum - Charting the Course of Community Pharmacies
Pharmacy Times
SEPTEMBER 26, 2023
Tune in to this episode of the Independent Rx Forum to gain a comprehensive understanding of the enduring significance of independent and community pharmacies.
Do humans have a place in pharma’s AI future?
PharmaVoice
SEPTEMBER 26, 2023
From COTA’s large datasets and AI model assistants to a company guiding patients through cancer care, AI can help — but it’s a long way from human-free.
Opinion: Policymakers must take action on the physician shortage
STAT
SEPTEMBER 25, 2023
The pressures of the last three and a half years have affected every corner of the health care landscape, but nowhere is the effect more evident than the country’s physician workforce. Burnout, staffing shortages, financial challenges, administrative burden, and two U.S. Supreme Court decisions that stand to stifle diversity and representation in medicine have hamstrung physicians across specialties and settings — in rural and urban communities, in hospitals, clinics, and independe
Unite Us, tech company focused on social determinants of health, lays off employees amid profitability struggles
Fierce Healthcare
SEPTEMBER 6, 2023
Unite Us, tech company focused on social determinants of health, lays off employees amid profitability struggles agliadkovskaya Wed, 09/06/2023 - 14:25
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
SEPTEMBER 7, 2023
Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. | Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. Analysts anticipate that the trend will continue in 2023 and into 2024 as companies attempt to beef up their portfolios.
FDA Grants Tentative Approval to Generic Triumpeq PD for Children With HIV
Drug Topics
SEPTEMBER 14, 2023
Abacavir/dolutegravir/lamivudine is a fixed-dose combination containing two nucleoside reverse transcriptase inhibitors (NRTIs) and integrase strand transfer inhibitor (INSTI).
FDA Approves Empagliflozin for Adults With Chronic Kidney Disease at Risk of Progression
Pharmacy Times
SEPTEMBER 22, 2023
Empagliflozin (Jardiance) demonstrated a 28% relative risk reduction, with an absolute risk reduction of 3.6% per patient-year at risk in the treatment of chronic kidney disease.
A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen?
PharmaVoice
SEPTEMBER 1, 2023
Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery route holds promise for far more drugs.
Let's personalize your content